Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

"She's just wired a different way," Stanford told MedPage Today, noting part of the consideration for using new GLP-1 ...

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Fox News medical contributor Dr. Nicole Saphier said changing America's food system is "not going to be an easy fix" while ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...